Alembic Pharma gets USFDA nod for generic version of Uloric tablets Farhat Nasim2 July 2019 6:19 AM GMTThe approved product, Febuxostat tablet is therapeutically equivalent to the reference listed drug Uloric tablets of Takeda Pharmaceuticals USA, Inc....
Novartis to pay $310 million for assets from inflammation specialist IFM Garima2 April 2019 3:30 AM GMTIFM, whose research head Martin Seidel spent more than a decade at Novartis before assuming R&D duties at IFM in 2017, focuses on immune system...